Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SoyLife 25
- Development stage
- Unknown
- Lead developer
- International Flavors & Fragrances
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
SoyLife 25 is a branded dietary supplement ingredient consisting of standardized soy germ extract rich in isoflavones, particularly daidzein. Manufactured by Frutarom Health (now part of International Flavors & Fragrances), it contains a high concentration of bioactive phytoestrogens derived exclusively from the germ portion of the soybean. Isoflavones are plant-derived compounds that can act as phytoestrogens—molecules structurally similar to human estrogen—which may exert weak estrogenic or anti-estrogenic effects depending on endogenous hormone levels. Clinical studies have shown that products containing SoyLife are associated with benefits for menopausal symptoms (such as hot flashes), bone health, and cardiovascular health; more recent research has explored potential cognitive and skin health benefits. The product is non-GMO and suitable for use in dietary supplements and functional foods[8][9].
- Brand names
- SoyLife 25SoyLife25SoyLife-25SoyLife
- Other names
- SoyLife 25SoyLife25SoyLife-25soy germ isoflavonessoy isoflavones (from soy germ)
02
Targets
KAT2BESR2 (ERβ)ESR1 (ERα)HDAC (HDAC family)KMT (Histone-lysine methyltransferases)
Beyond the preview
Go deeper on SoyLife 25.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SoyLife 25.